Data from: Preclinical toxicity and pharmacokinetics of a new orally bioavailable flubendazole formulation and the impact for clinical trials and r

负责人：

Lammens, Lieve

关键词：

flubendazole toxicity pharmacokinetics risk/benefit

DOI：

doi:10.5061/dryad.5vv774m

摘要：

Background: Flubendazole, originally developed to treat infections with intestinal nematodes, has been shown to be efficacious in animal models